Top executives from Bristol Myers Squibb, Johnson & Johnson, AbbVie and AstraZeneca, which have five of the 10 drugs chosen for the first wave of negotiations, described their newly informed views on quarterly conference calls.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/HhgIf3r
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment